FILTER
FILTERED INTERVIEW RESULTS
Michel Gilbert
INTERIM PRESIDENT AND CEO & ENGINEER, SOQUEM
SOQUEM was founded in 1965 and has played an instrumental role in Quebec’s mining industry by helping to broaden the range of natural resources under development.
Michel Champagne
PRESIDENT & CEO, SIDEX
SIDEX is an institutional fund that invests in companies engaged in mineral exploration in Québec.
Randy Smallwood
PRESIDENT & CEO, WHEATON PRECIOUS METALS
Wheaton Precious Metals is one of the world’s largest precious metals streaming companies.
Duane Nelson
CEO AND DIRECTOR, ENVIROLEACH
EnviroLeach offers gold miners an alternative for cyanide and explores recycling techniques
Philippe Cloutier
CEO, CARTIER RESOURCES
Cartier Resources is a junior gold exploration company focused on the Abitibi greenstone belt in Quebec.
Dean Journeaux
COFOUNDER AND BOARD MEMBER, NEW MILLENNIUM IRON (NML)
New Millennium Iron Corp. (NML) has actively explored properties in Canada's Labrador Trough and is now at the development stage.
Andrew Wilkins
VICE PRESIDENT, BUSINESS DEVELOPMENT AND MARKETING, DISTRIBUTED GAS SOLUTIONS CANADA (DGSC)
DGSC works with mining companies to provide customized supply solutions for dis-tributed Liquefied Natural Gas (LNG) and Compressed Natural Gas (CNG) across Canada.
Dominique Doucet
FOUNDER & CEO, SIRIOS RESOURCES
Pioneers in the discovery of world-class gold deposits in the James Bay region, Sirios has discovered numerous showings in Nord-du-Québec and Eastern Canada.
Bill Xue
PRESIDENT & CEO, WESTERN RESOURCES
TSX-listed Western Resources’ wholly owned subsidiary Western Potash Corp is fo-cused on developing the Milestone potash project in Saskatchewan.
Glenn J. Mullan
P.Geo ICD.D. CHAIRMAN OF THE BOARD, President & CEO, GOLDEN VALLEY MINES
Golden Valley Mines is based in Quebec and focused on early exploration and grassroots project generation in Canada and beyond.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
